Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine Era. S Miguel, M Domenech, F González-Camacho, J Sempere, D Vicioso, ... Clinical Infectious Diseases 73 (11), 2021 | 85 | 2021 |
Clinical relevance and molecular pathogenesis of the emerging serotypes 22F and 33F of Streptococcus pneumoniae in Spain J Sempere, S De Miguel, F González-Camacho, J Yuste, M Domenech Frontiers in Microbiology 11, 511480, 2020 | 42 | 2020 |
Combination of antibodies and antibiotics as a promising strategy against multidrug-resistant pathogens of the respiratory tract M Domenech, J Sempere, S de Miguel, J Yuste Frontiers in immunology 9, 2700, 2018 | 36 | 2018 |
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in … J Sempere, M Llamosí, BL Ruiz, I Del Río, C Pérez-García, D Lago, ... The Lancet Microbe 3 (10), e744-e752, 2022 | 33 | 2022 |
Pneumococcal choline-binding proteins involved in virulence as vaccine candidates J Sempere, M Llamosi, I del Río Menéndez, B Lopez Ruiz, M Domenech, ... Vaccines 9 (2), 181, 2021 | 15 | 2021 |
Clearance of mixed biofilms of Streptococcus pneumoniae and methicillin-susceptible/resistant Staphylococcus aureus by antioxidants N-acetyl-l-cysteine and … J Sempere, M Llamosí, F Román, D Lago, F González-Camacho, ... Scientific reports 12 (1), 6668, 2022 | 14 | 2022 |
A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period … J Sempere, F González-Camacho, M Domenech, M Llamosí, I Del Río, ... Journal of Antimicrobial Chemotherapy 77 (4), 1045-1051, 2022 | 14 | 2022 |
Minilungs from human embryonic stem cells to study the interaction of streptococcus pneumoniae with the respiratory tract J Sempere, SA Rossi, I Chamorro-Herrero, F González-Camacho, ... Microbiology Spectrum 10 (3), e00453-22, 2022 | 9 | 2022 |
Improvement of the Antibacterial Activity of Phage Lysin-Derived Peptide P87 through Maximization of Physicochemical Properties and Assessment of Its Therapeutic Potential R Vázquez, A Doménech-Sánchez, S Ruiz, J Sempere, J Yuste, S Albertí, ... Antibiotics 11 (10), 1448, 2022 | 5 | 2022 |
Combination of Cefditoren and N-acetyl-l-Cysteine Shows a Synergistic Effect against Multidrug-Resistant Streptococcus pneumoniae Biofilms M Llamosí, J Sempere, P Coronel, M Gimeno, J Yuste, M Domenech Microbiology Spectrum 10 (6), e03415-22, 2022 | 2 | 2022 |
Control of microbial agents by functionalization of commercial air filters with metal oxide particles B Ribeiro, A Vázquez-López, M Vazquez-Pufleau, M Llamosí, J Sempere, ... Materials Chemistry and Physics 313, 128684, 2024 | 1 | 2024 |
Nasopharyngeal colonization and invasive disease in Streptococcus pneumoniae: Two critical aspects of the pneumococcal pathogenesis with many similarities J Sempere, J Yuste Enfermedades infecciosas y microbiologia clinica (English ed.) 42 (4), 169-171, 2024 | | 2024 |
Invasive disease caused simultaneously by two different serotypes of Streptococcus pneumoniae: a microbiological appreciation E Cercenado, B Ramos, M Pérez-Abeledo, J Sempere, J Yuste, JC Sanz European Journal of Clinical Microbiology & Infectious Diseases, 1-4, 2024 | | 2024 |
Streptococcus pneumoniae y Staphylococcus aureus: enfermedad invasiva, biofilm y terapia J Sempere García Universidad Complutense de Madrid, 2022 | | 2022 |
IE-7951. Evolución epidemiológica de los nuevos serotipos vacunales 22F y 33F de Streptococcus pneumoniae en España incluyendo el impacto de la pandemia por SARS-CoV-2 J Sempere, S Ruiz, D Rico, S de Miguel, M Domenech, J Yuste Vacunas 23, 17-18, 2022 | | 2022 |
IE-7925. Contribución de las vacunas antineumocócicas y la pandemia por SARS-CoV-2 en la evolución epidemiológica de la enfermedad neumocócica invasiva en España S de Miguel, J Sempere, S Hita, J Llorente, M Domenech, J Yuste Vacunas 23, 15-16, 2022 | | 2022 |
IE-7950. Contribución de las vacunas conjugadas antineumocócicas y el SARS-CoV-2 a la resistencia a antibióticos en Streptococcus pneumoniae en España durante el periodo 2004-2020 J Sempere, C Pérez-García, D Lago, S Hita, M Domenech, J Yuste Vacunas 23, 17, 2022 | | 2022 |
Minilungs from hESCs to study the interaction of Streptococcus pneumoniae with the respiratory tract F González-Camacho, SA Rossi, J Sempere, MP de Lucas, ... bioRxiv, 2022.02. 01.478764, 2022 | | 2022 |
Actualización sobre la vacuna antineumocócica conjugada 20-valente J Sempere, S Hita, C Pérez, D Lago, M Domenech, J Yuste Fernando A. Moraga Llop, 15, 2021 | | 2021 |
1515. Nationwide trends of invasive pneumococcal disease in Spain for the period 2009-2019 S de Miguel, M Domenech, J Sempere, F González-Camacho, J Yuste Open Forum Infectious Diseases 7 (Suppl 1), S760, 2020 | | 2020 |